Purchases and Sales Made in Q2 2024 in Collegium Pharmaceutical, Inc (COLL)
This table provides information about the institutional ownership of Collegium Pharmaceutical, Inc (COLL) during Q2 2024. The information is specifically focused on institutions that hold shares of COLLEGIUM PHARMACEUTICAL, INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-206K- 24.6% |
$6.46M - $8.23M
|
631K
$20.6M
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-206K- 24.6% |
$6.46M - $8.23M
|
631K
$20.6M
|
|
|
Aug 14, 2024
Q2 2024
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-244K- 67.63% |
$7.66M - $9.77M
|
117K
$3.81M
|
|
|
Aug 14, 2024
Q2 2024
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-549K- 97.53% |
$17.2M - $22M
|
13.9K
$453K
|